Global Generics & Biosimilars Awards Finalists
Congratulations to all of our finalists for 2019.
Our expert judges have assessed all the entries for the Global Generics & Biosimilars Awards 2019 to create the shortlist of Award finalists.
Accord |
Pelgraz (pegylated filgrastim) |
Arven Pharmaceuticals | Filgrastim prefilled syringe SC/IV infusion 30 miu/0.5 ml |
mAbxience |
The expansion of bevacizumab worldwide |
Sandoz | Agreement with Gan & Lee to commercialize and supply biosimilars of top three insulins |
Shanghai Henlius Biotech | HLX01 (Rituximab Injection, Recombinant Human/Murine Chimeric Anti-CD20 Monoclonal Antibody Injection) |
Stada |
Expansion of strategic biosimilar development partnership with Xbrane |
Acquisition of the Year
Alvogen |
Exeltis product acquisition, including 23 brands |
Aurobindo | Acquisition of dermatology and oral solids businesses from Sandoz |
Eurofarma | Eurofarma reinforces its presence in Chile with the acquisition of Medipharm |
Zentiva | Acquisition of Solacium Pharma (including Be Well Pharma) and Creo Pharma |
Leader of the Year
Accord |
Binish Chudgar |
Aurobindo | PV Ramprasad Reddy |
Hikma | Siggi Olafsson |
mAbxience | Emmanuelle Lepine |
Stada | Peter Goldschmidt |
Zentiva | Nick Haggar |
Industry Partner of the Year
Kit Check
Lambda Therapeutic Research
Pharmathen
Piramal Pharma Solutions
Rephine
West Pharma
Value Added Medicine Initiative of the Year
Accord |
Methofill pre-filled syringe and SelfDose injector |
Intas | Solifenacin orodispersible (fast-disintegrating) tablet |
PharmEvo | Orodispersible powder with micro encapsulated iron |
Stada | Anti-cancer drug bortezomib |
Business Development of the Year
Accord |
Licensing of leuprorelin depot Injectable for global markets |
Dr Reddy's | Engagement with clients through its no-boundary portal XCEED |
PharmEvo | Orodispersible powder with micro encapsulated iron |
Piramal Pharma Solutions | Patent challenge and launch of treatment for secondary hyperthyroidism |
Stada | Expansion of strategic biosimilar development partnership with Xbrane |
West Pharma |
The West AccelTRA elastomer components program |
Regulatory Achievement of the Year
Alvogen |
Oral vinorelbine softgels |
Insud Pharma-Chemo |
Duta Tamsu |
Intas | Olmesartan/amlodipine/HCTZ fixed-dose combination |
Lupin | Moxonidine tablets and valproate semisodium |
Pharmathen | Long acting injectable (LAI) programs. |
Sandoz | Generic approval under China’s QCE system |
Legal Strategy of the Year
Accord & Aspire |
Challenge of the bimatoprost 0.01% patent in the UK |
Alvogen | US Revlimid settlement / launch of a Suboxone rival |
Dr Reddy's | Suboxone buprenorphine/naloxone sublingual films |
Stada | Launch of anti-cancer drug bortezomib |
Corporate Social Responsibility (CSR) Initiative of the Year
Accord |
Taking care of our environment, community and people |
Dr Reddy's | Marking Integrated Transformation for Resourceful Agriculture (MITRA) |
Hikma |
Dedicated to putting high-quality medicines in reach of patients |
Insud Pharma |
Not a single baby with Chagas disease |
Sandoz |
Sandoz HACk – Healthcare Access Challenge |
Teva |
Increasing Access to Medicine |
For 2020 Sponsorship Opportunities contact:
Christopher Keeling
Tel: +44 (0) 7917 647 859
Email: christopher.keeling@informa.com
For all other enquiries:
Jo Kirkpatrick
Tel: +44 (0) 7917 555 986
Email: jo.kirkpatrick@informa.com